IntrinsicIntrinsic
← Scroll for more →

Financial Statements — MEDP

Balance Sheet

(in billions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents0.710.500.650.500.290.050.440.670.660.510.410.250.100.040.050.030.030.040.080.46
Accounts Receivable0.450.440.390.400.370.380.300.300.310.300.280.300.290.280.260.250.250.230.220.19
Total Current Assets1.251.051.140.990.740.520.821.031.030.870.740.590.450.380.370.330.340.330.360.69
Property, Plant & Equipment0.180.160.140.130.130.140.130.120.120.120.120.120.110.110.110.110.100.100.100.09
Goodwill0.660.660.660.660.660.660.660.660.660.660.660.660.660.660.660.660.660.660.660.66
Intangible Assets0.000.000.000.000.000.000.000.000.000.000.000.000.000.010.010.010.010.010.010.01
Total Non-current Assets*1.061.010.990.991.021.051.081.071.051.051.051.061.041.031.031.020.990.990.990.97
Total Assets2.302.062.131.981.751.571.902.102.081.921.801.661.491.411.401.351.331.321.341.66
Accounts Payable0.040.040.030.030.030.040.060.030.030.030.020.030.030.030.040.030.030.030.030.03
Short-term Debt----------------------0.000.000.060.120.050.140.25----
Total Current Liabilities1.501.441.351.341.281.221.121.101.040.990.960.930.850.850.880.800.820.880.580.56
Total Non-current Liabilities*0.220.190.190.170.180.180.180.170.160.160.170.170.170.160.170.160.160.150.160.15
Total Liabilities1.721.621.531.521.461.401.301.281.201.161.121.101.021.021.050.970.981.030.740.71
Retained Earnings(0.37)(0.51)(0.34)(0.46)(0.60)(0.70)(0.27)0.010.07(0.03)(0.12)(0.22)(0.30)(0.37)(0.41)(0.36)(0.38)(0.45)(0.12)0.23
Total Stockholder Equity0.580.430.600.460.290.170.590.830.880.760.670.560.470.390.350.390.350.280.610.95
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Total Revenue716.00707.33706.60708.45659.90603.31558.57536.59533.32528.10511.04498.40492.50460.87434.07394.10383.74351.21330.95308.55
Selling, General & Admin51.7748.1047.9244.9248.0846.6657.9045.4349.2241.4544.0842.5141.4139.4038.0333.4035.4233.2229.3727.66
Operating Income165.54146.82141.50153.27141.81126.34113.52125.38112.27105.15104.0787.3284.9178.3986.2076.4377.8360.2464.2054.86
Pretax Income170.91151.66147.59156.83142.84124.54118.17133.88118.78110.48112.7890.7183.2075.7486.0373.6581.8962.0065.3255.92
Tax Provision33.4530.3023.7221.7031.7034.283.5816.8622.3522.1310.1912.4112.6514.6813.144.9715.8712.644.015.89
Net Income137.46121.36123.87135.13111.1490.26114.60117.0296.4388.35102.5978.3070.5561.0772.8968.6766.0349.3661.3150.03
Basic EPS4.924.314.354.763.953.163.773.783.112.853.322.552.302.002.352.172.131.521.751.39
Diluted EPS4.844.254.284.653.863.103.673.673.012.753.202.462.221.932.272.082.051.461.691.32
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Operating Cash Flow216.60162.01151.79192.65246.21148.53125.84190.67149.07116.40152.68156.40114.3982.5280.08136.68108.4996.6246.2670.89
Capital Expenditures20.1623.916.814.5410.716.119.997.6410.5412.875.509.998.708.459.519.247.1811.209.269.12
Free Cash Flow*196.44138.10144.97188.12235.50142.41115.84183.02138.54103.53147.18146.41105.6874.0770.56127.44101.3185.4237.0061.78
Investing Cash Flow(20.14)(23.88)(6.75)(4.47)(10.66)(6.02)(9.99)(7.56)(10.49)(12.79)2.53(8.00)(8.66)(8.47)(9.50)(9.22)(7.19)(11.13)(11.21)(9.12)
Financing Cash Flow6.50(288.34)12.6722.733.41(540.56)(345.97)(168.61)6.270.677.661.52(49.27)(82.21)(52.68)(131.12)(109.11)(123.46)(412.08)2.43
← Scroll for more columns →

* Derived from reported values